“…On the other hand, lower levels of DHA have been associated with neuronal membrane instability and dysfunctional transmission of serotonin, norepinephrine, and dopamine, which might be associated with mood and cognitive disfunction [ 24 , 25 , 26 ]. On the basis of these preclinical findings, several lines of evidence support the importance of n-3 PUFAs in the treatment of psychiatric disorders such as schizophrenia, major depression, bipolar disorder, anxiety disorders, obsessive-compulsive disorder, post-traumatic stress disorder, attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, eating disorders, substance use disorder, and borderline personality disorder [ 27 , 28 , 29 , 30 , 31 ]. Furthermore, in a trans-diagnostic perspective, recent studies have pointed out that supplementation with n-3 PUFAs provides benefits on the main psychiatric symptom dimensions, particularly in domains of psychotic symptoms, affective symptoms, impulsivity, and harmful behaviours [ 32 , 33 , 34 ].…”